These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15494410)

  • 1. Hsp70 and Hsp40 chaperones do not modulate retinal phenotype in SCA7 mice.
    Helmlinger D; Bonnet J; Mandel JL; Trottier Y; Devys D
    J Biol Chem; 2004 Dec; 279(53):55969-77. PubMed ID: 15494410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease progression despite early loss of polyglutamine protein expression in SCA7 mouse model.
    Helmlinger D; Abou-Sleymane G; Yvert G; Rousseau S; Weber C; Trottier Y; Mandel JL; Devys D
    J Neurosci; 2004 Feb; 24(8):1881-7. PubMed ID: 14985428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice.
    Yvert G; Lindenberg KS; Picaud S; Landwehrmeyer GB; Sahel JA; Mandel JL
    Hum Mol Genet; 2000 Oct; 9(17):2491-506. PubMed ID: 11030754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity.
    Jana NR; Tanaka M; Wang Gh; Nukina N
    Hum Mol Genet; 2000 Aug; 9(13):2009-18. PubMed ID: 10942430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.
    Cummings CJ; Mancini MA; Antalffy B; DeFranco DB; Orr HT; Zoghbi HY
    Nat Genet; 1998 Jun; 19(2):148-54. PubMed ID: 9620770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease.
    Chai Y; Koppenhafer SL; Bonini NM; Paulson HL
    J Neurosci; 1999 Dec; 19(23):10338-47. PubMed ID: 10575031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7.
    La Spada AR; Fu YH; Sopher BL; Libby RT; Wang X; Li LY; Einum DD; Huang J; Possin DE; Smith AC; Martinez RA; Koszdin KL; Treuting PM; Ware CB; Hurley JB; Ptácek LJ; Chen S
    Neuron; 2001 Sep; 31(6):913-27. PubMed ID: 11580893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: proteins recruited in inclusions and activation of caspase-3.
    Zander C; Takahashi J; El Hachimi KH; Fujigasaki H; Albanese V; Lebre AS; Stevanin G; Duyckaerts C; Brice A
    Hum Mol Genet; 2001 Oct; 10(22):2569-79. PubMed ID: 11709544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ataxia protein sacsin is a functional co-chaperone that protects against polyglutamine-expanded ataxin-1.
    Parfitt DA; Michael GJ; Vermeulen EG; Prodromou NV; Webb TR; Gallo JM; Cheetham ME; Nicoll WS; Blatch GL; Chapple JP
    Hum Mol Genet; 2009 May; 18(9):1556-65. PubMed ID: 19208651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7.
    Janer A; Werner A; Takahashi-Fujigasaki J; Daret A; Fujigasaki H; Takada K; Duyckaerts C; Brice A; Dejean A; Sittler A
    Hum Mol Genet; 2010 Jan; 19(1):181-95. PubMed ID: 19843541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCA7 mouse models show selective stabilization of mutant ataxin-7 and similar cellular responses in different neuronal cell types.
    Yvert G; Lindenberg KS; Devys D; Helmlinger D; Landwehrmeyer GB; Mandel JL
    Hum Mol Genet; 2001 Aug; 10(16):1679-92. PubMed ID: 11487572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous purkinje cell degeneration and displays proteolytic cleavage in ataxic transgenic mice.
    Garden GA; Libby RT; Fu YH; Kinoshita Y; Huang J; Possin DE; Smith AC; Martinez RA; Fine GC; Grote SK; Ware CB; Einum DD; Morrison RS; Ptacek LJ; Sopher BL; La Spada AR
    J Neurosci; 2002 Jun; 22(12):4897-905. PubMed ID: 12077187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy.
    Abu-Baker A; Messaed C; Laganiere J; Gaspar C; Brais B; Rouleau GA
    Hum Mol Genet; 2003 Oct; 12(20):2609-23. PubMed ID: 12944420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chaperone suppression of cellular toxicity of huntingtin is independent of polyglutamine aggregation.
    Zhou H; Li SH; Li XJ
    J Biol Chem; 2001 Dec; 276(51):48417-24. PubMed ID: 11606565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract.
    Kobayashi Y; Kume A; Li M; Doyu M; Hata M; Ohtsuka K; Sobue G
    J Biol Chem; 2000 Mar; 275(12):8772-8. PubMed ID: 10722721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.
    Warrick JM; Chan HY; Gray-Board GL; Chai Y; Paulson HL; Bonini NM
    Nat Genet; 1999 Dec; 23(4):425-8. PubMed ID: 10581028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
    Cummings CJ; Orr HT; Zoghbi HY
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conditional pan-neuronal Drosophila model of spinocerebellar ataxia 7 with a reversible adult phenotype suitable for identifying modifier genes.
    Latouche M; Lasbleiz C; Martin E; Monnier V; Debeir T; Mouatt-Prigent A; Muriel MP; Morel L; Ruberg M; Brice A; Stevanin G; Tricoire H
    J Neurosci; 2007 Mar; 27(10):2483-92. PubMed ID: 17344386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of protein aggregation by chaperone modification of high molecular weight complexes.
    Labbadia J; Novoselov SS; Bett JS; Weiss A; Paganetti P; Bates GP; Cheetham ME
    Brain; 2012 Apr; 135(Pt 4):1180-96. PubMed ID: 22396390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H1152 promotes the degradation of polyglutamine-expanded ataxin-3 or ataxin-7 independently of its ROCK-inhibiting effect and ameliorates mutant ataxin-3-induced neurodegeneration in the SCA3 transgenic mouse.
    Wang HL; Hu SH; Chou AH; Wang SS; Weng YH; Yeh TH
    Neuropharmacology; 2013 Jul; 70():1-11. PubMed ID: 23347954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.